return2ozma@lemmy.world to News@lemmy.world · 5 months agoOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comexternal-linkmessage-square160fedilinkarrow-up1618arrow-down117cross-posted to: piracy@lemmy.dbzer0.com
arrow-up1601arrow-down1external-linkOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comreturn2ozma@lemmy.world to News@lemmy.world · 5 months agomessage-square160fedilinkcross-posted to: piracy@lemmy.dbzer0.com
minus-squareEnderMB@lemmy.worldlinkfedilinkarrow-up7·5 months agoI’m sure there are some costs associated with developing drugs, and I’m sure it’s not cheap. The problem still stands, though, and the solution is capping executive pay in public companies.
I’m sure there are some costs associated with developing drugs, and I’m sure it’s not cheap.
The problem still stands, though, and the solution is capping executive pay in public companies.